+987.9%
MRNA vs ZBRA
+25.3%
+962.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ZBRA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +0.9% | +12.2% | +13.2% |
| 7D | +20.6% | -13.6% | +34.2% | +19.7% |
| 30D | +27.1% | -11.5% | +38.7% | +26.3% |
| 3M | +353.4% | -9.9% | +363.2% | +353.0% |
| 6M | +446.3% | +48.6% | +397.7% | +384.6% |
| YTD | +776.2% | +36.9% | +739.3% | +653.8% |
| 1Y | +987.9% | +27.7% | +960.2% | +880.7% |
| All | +987.9% | +25.3% | +962.6% | +880.7% |
Cumulative growth
Daily Returns
Daily percentage return beside ZBRA.
Daily Out/Under-Performance
Portfolio return minus ZBRA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ZBRA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ZBRA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling